Company-wide revenue
Reported revenue in 2021 ¥560.03B Reported revenue in 2025 ¥453.29B
- growth amount
- −¥106.74B
- growth annualized
- -5.1%
- growth total
- -19.1%
Japanese company profile · 4506
English company name recorded in Japan's EDINET filer data.
Original Japanese company name: 住友ファーマ株式会社
Name follows the English name recorded in EDINET filer data. English company name source
FY2025 · fiscal year ended March 2026Latest filing date: 2026-06-23What does this company do?
In its FY2025 public filing, Sumitomo Pharma Co., Ltd. reports Japan, North America, Asia. The page shows business-level revenue and profit where the source disclosures support comparison.
Sumitomo Pharma Co., Ltd.'s largest reported business by revenue in FY2025 was North America.
The business with the highest reported segment profit in FY2025 was North America.
FY2025 · fiscal year ended March 2026 · View original filing ↗ The source document may be in Japanese.
IFRS · Consolidated company-wide
Public information is organized and presented by P16. EDINET filer list (2026-11-07) Opens in a new tab · EDINET PDL 1.0 terms Opens in a new tab
Business structure
North America
| Business | Revenue from external customers | Share of company sales | Segment profit (loss) | Margin |
|---|---|---|---|---|
| North America | ¥337.92B ↗ | — | ¥75.74B ↗ | 22.4% |
| Japan | ¥92.36B ↗ | — | ¥12.35B ↗ | 13.4% |
| Asia | ¥23.01B ↗ | — | ¥9.45B ↗ | 41.1% |
All values are in Japanese yen (JPY). No currency conversion is applied. FY2025 · fiscal year ended March 2026. Revenue and profit are shown only where the filing and data support a comparison. “—” means a comparable amount was not disclosed. We compare sales to outside customers for each business and the company as a whole, using the same filing, fiscal year and scope. Reported business sales may include sales between businesses. We leave the share blank when the figures cannot be matched.
Company revenue
Only reported years are shown. Missing years are left blank; accounting standards and scopes are kept in separate series.
What has changed?
Reporting labels alone do not prove that a business started, ended, merged, or changed its identity.
Reported Revenue from external customers by business over time
| Fiscal year | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|
| Japan | ¥149.91B | ¥126.11B | ¥114.66B | ¥99.84B | ¥92.36B |
| North America | ¥319.79B | ¥328.47B | ¥159.04B | ¥251.81B | ¥337.92B |
| Asia | — | — | ¥40.86B | ¥47.18B | ¥23.01B |
| China | ¥38.3B | ¥39.4B | — | — | — |
| Overseas and Other Businesses | ¥12.18B | ¥16.75B | — | — | — |
All amounts are in Japanese yen (JPY). Each figure links to the original Japanese filing. Blank cells indicate no comparable figure was disclosed. Business figures may not add up to consolidated figures.
What is growing?
Reported revenue in 2021 ¥560.03B Reported revenue in 2025 ¥453.29B
This describes a reported period; it is not a forecast.
What has changed?
A five-year business-mix comparison is not shown because the available filings do not provide five comparable years on the same basis.
Source
These scores summarize company characteristics using public filings. Comparison groups vary by measure. Higher is not always better.
Source
FY2025 · fiscal year ended March 2026
The source document may be in Japanese.
Filing ID: S100YH3M
View original filing ↗